FRC
FRC Logo
CommunityMarkets
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileQuest Diagnostics Incorporated
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
DGX
Quest Diagnostics Incorporated Stock AnalysisComprehensive stock analysis for Quest Diagnostics Incorporated (DGX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisDGX
DGX
Quest Diagnostics Incorporated
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
DGX
  1. Home
  2. Stocks
  3. Quest Diagnostics Incorporated

Quest Diagnostics Incorporated

🇺🇸DGX•NYSE

Quest Diagnostics Incorporated

🇺🇸DGX•NYSE
Market cap
$28.85B
Sentiment

Your view on DGX

Mkt Cap
$28.85B
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Quest Diagnostics Incorporated

Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
James E. Davis
Headquarters
500 Plaza Drive, Secaucus, NJ, US
Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
James E. Davis
Headquarters
500 Plaza Drive, Secaucus, NJ, US
Description

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.

It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals.

The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Financial Data

Stock Data

Price chart, volume, and trading data.

What moved it

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for Quest Diagnostics Incorporated from FRC's valuation model, read against the market price. DGX last traded at $262.21, 25.7× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Quest Diagnostics Incorporated. Starting points for Quest Diagnostics Incorporated: P/E 25.7, EPS $10.26, beta 0.55 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Quest Diagnostics Incorporated. Quest Diagnostics Incorporated paid $3.38 per share over the last year — a 1.3% yield at the current $262.21 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Quest Diagnostics Incorporated. Trailing twelve-month EPS for Quest Diagnostics Incorporated stands at $10.26. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 18, 2026 · USD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Current price

—

live quote

Analysts' target

$249.62

average of 8 firms, last 12 months

 

$249.62

Low $225.00

Median $255.00

High $262.00

 

Analyst Ratings

Hold9 firms, last 12 months
  • Strong Buy0
  • Buy3
  • Hold6
  • Sell0
  • Strong Sell0

Earnings Estimate

EPSCurrent QtrDec 2026Next QtrMar 2027Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate$2.68$2.70$11.32$11.98
Low estimate$2.66$2.60$11.28$11.71
High estimate$2.70$2.85$11.34$12.35
No. of analysts1081111
Year-ago EPS$2.42$2.50$8.75—
Growth+10.9%+7.9%+29.3%—

Revenue Estimate

RevenueCurrent QtrDec 2026Next QtrMar 2027Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate$3.04B$3.03B$12.08B$12.63B
Low estimate$3.01B$3.00B$12.06B$12.55B
High estimate$3.08B$3.04B$12.10B$12.66B
No. of analysts971313
Year-ago revenue$2.81B$2.90B$11.04B—
Growth+8.4%+4.6%+9.5%—
Recent analyst actions15 rating and price-target changes, latest Oct 23, 2026 — with the analyst, firm and source

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga, Pulse 2.0, Investing; as of Nov 18, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Quest Diagnostics Incorporated. Quest Diagnostics Incorporated has reported as a listed company since 1996. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold DGX20 companies · 7 funds
Compare DGX with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis

Peer companies

Market cap

  • BMXXYbioMérieux S.A.Medical - Diagnostics & Research$17.2B
  • GHGuardant Health, Inc.Medical - Diagnostics & Research$19.5B
  • GRALGRAIL, Inc.Medical - Diagnostics & Research$4.7B
  • ILMNIllumina, Inc.Medical - Diagnostics & Research$29.9B
  • LHLabcorp Holdings Inc.Medical - Diagnostics & Research$30.2B
  • NTRANatera, Inc.Medical - Diagnostics & Research$41.8B
  • QGENQiagen N.V.Medical - Diagnostics & Research$10.3B
  • RDNTRadNet, Inc.Medical - Diagnostics & Research$6.1B

More Medical - Diagnostics & Research companies

  • MBGNFMany Bright Ideas Technologies Inc.OTC$101,821
  • MDXHMDxHealth S.A.NASDAQ$14M
  • MEDDMedical Imaging Corp.OTC$63,819
  • MEDPMedpace Holdings, Inc.NASDAQ$18.1B
  • MEDVFMedivolve Inc.OTC$54,038
  • MRCHFH.U. Group Holdings, Inc.OTC$1.1B
  • MRPSMicrophonics, Inc.OTC
  • MTDMettler-Toledo International Inc.NYSE$34.4B
  • MVF.AXMonash IVF Group LimitedASX
  • MYGNMyriad Genetics, Inc.NASDAQ$534M
  • NDRAENDRA Life Sciences Inc.NASDAQ$7M
  • NEONeoGenomics, Inc.NASDAQ$2.0B

ETFs holding Quest Diagnostics Incorporated

% of the fund

  • VOOVanguard S&P 500 ETF$1.0T in assets0.04%
  • VTIVanguard Total Stock Market ETF$689.2B in assets0.04%
  • VOVanguard Mid-Cap ETF$103.4B in assets0.27%
  • IVViShares Core SP 500 ETF$852.9B in assets0.04%
  • PINKSimplify Health Care ETF$352M in assets3.63%
  • IHFiShares US Healthcare Providers ETF$1.5B in assets3.51%
  • ZLU.TOBMO Low Volatility US Equity ETF$2.6B in assets1.83%

Largest holders first, then the funds most concentrated in DGX.

Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Quest Diagnostics Incorporated, and how their positions are changing. At a $28.85B market value, institutional positions materially move Quest Diagnostics Incorporated's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Quest Diagnostics Incorporated executives and directors. Shares of Quest Diagnostics Incorporated have traded between $148.70 and $197.55 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

About this section

U.S. Senate disclosures naming Quest Diagnostics Incorporated. Quest Diagnostics Incorporated is a $28.85B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

About this section

U.S. House of Representatives disclosures naming Quest Diagnostics Incorporated. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Quest Diagnostics Incorporated. Coverage tracks Quest Diagnostics Incorporated within Medical - Diagnostics & Research (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Quest Diagnostics Incorporated.

DGX Analysis
Fair
Past4
Growth3
Health3
Profit3
Value1

News

Latest Market News